Natixis’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Hold |
500,000
| – | – | 0.18% | 74 |
|
|
2025
Q1 | $40.3M | Buy |
+500,000
| New | +$40.3M | 0.22% | 65 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$249 | – | 1165 |
|
|
2022
Q4 | $249 | Buy |
+3
| New | +$249 | ﹤0.01% | 991 |
|
|
2020
Q4 | – | Sell |
-1,000,000
| Closed | -$111M | – | 1111 |
|
|
2020
Q3 | $111M | Buy |
+1,000,000
| New | +$111M | 0.82% | 29 |
|
|
2020
Q2 | – | Sell |
-2,000,000
| Closed | -$155M | – | 869 |
|
|
2020
Q1 | $155M | Hold |
2,000,000
| – | – | 1.22% | 12 |
|
|
2019
Q4 | $190M | Buy |
2,000,000
+1,960,460
| +4,958% | +$187M | 1.18% | 7 |
|
|
2019
Q3 | $3.02M | Buy |
39,540
+8,929
| +29% | +$681K | 0.02% | 433 |
|
|
2019
Q2 | $2.69M | Sell |
30,611
-1,229
| -4% | -$108K | 0.02% | 409 |
|
|
2019
Q1 | $2.83M | Sell |
31,840
-39,015
| -55% | -$3.47M | 0.02% | 458 |
|
|
2018
Q4 | $5.08M | Buy |
70,855
+30,561
| +76% | +$2.19M | 0.04% | 319 |
|
|
2018
Q3 | $3.86M | Sell |
40,294
-9,204
| -19% | -$882K | 0.02% | 412 |
|
|
2018
Q2 | $4.71M | Buy |
49,498
+2,594
| +6% | +$247K | 0.02% | 389 |
|
|
2018
Q1 | $4.12M | Buy |
46,904
+14,806
| +46% | +$1.3M | 0.03% | 395 |
|
|
2017
Q4 | $2.72M | Buy |
32,098
+9,250
| +40% | +$785K | 0.02% | 373 |
|
|
2017
Q3 | $1.98M | Sell |
22,848
-327,152
| -93% | -$28.3M | 0.02% | 417 |
|
|
2017
Q2 | $27M | Buy |
350,000
+225,028
| +180% | +$17.4M | 0.31% | 84 |
|
|
2017
Q1 | $8.66M | Buy |
124,972
+41,667
| +50% | +$2.89M | 0.11% | 183 |
|
|
2016
Q4 | $4.93M | Buy |
83,305
+23,656
| +40% | +$1.4M | 0.05% | 263 |
|
|
2016
Q3 | $3.95M | Buy |
+59,649
| New | +$3.95M | 0.05% | 217 |
|
|
2015
Q4 | – | Sell |
-8,364
| Closed | -$521K | – | 374 |
|
|
2015
Q3 | $521K | Buy |
8,364
+2,424
| +41% | +$151K | 0.01% | 193 |
|
|
2015
Q2 | $499K | Buy |
+5,940
| New | +$499K | 0.01% | 257 |
|